421 related articles for article (PubMed ID: 33349222)
1. Anti-EGFR-mAb and 5-Fluorouracil Conjugated Polymeric Nanoparticles for Colorectal Cancer.
Bhattacharya S
Recent Pat Anticancer Drug Discov; 2021; 16(1):84-100. PubMed ID: 33349222
[TBL] [Abstract][Full Text] [Related]
2. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
[TBL] [Abstract][Full Text] [Related]
3. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma.
Srivastava S; Gupta S; Mohammad S; Ahmad I
J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208
[TBL] [Abstract][Full Text] [Related]
4. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody.
Eivazi N; Rahmani R; Paknejad M
Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796
[TBL] [Abstract][Full Text] [Related]
5. Chondroitin sulphate decorated nanoparticulate carriers of 5-fluorouracil: development and in vitro characterization.
Yadav AK; Agarwal A; Jain S; Mishra AK; Bid H; Rai G; Agrawal H; Agrawal GP
J Biomed Nanotechnol; 2010 Aug; 6(4):340-50. PubMed ID: 21323107
[TBL] [Abstract][Full Text] [Related]
6. Antibody Conjugated PLGA Nanocarriers and Superparmagnetic Nanoparticles for Targeted Delivery of Oxaliplatin to Cells from Colorectal Carcinoma.
Zumaya ALV; Rimpelová S; Štějdířová M; Ulbrich P; Vilčáková J; Hassouna F
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163122
[TBL] [Abstract][Full Text] [Related]
7. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil.
El-Hammadi MM; Delgado ÁV; Melguizo C; Prados JC; Arias JL
Int J Pharm; 2017 Jan; 516(1-2):61-70. PubMed ID: 27825867
[TBL] [Abstract][Full Text] [Related]
8. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.
Li X; Xu Y; Chen G; Wei P; Ping Q
Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762
[TBL] [Abstract][Full Text] [Related]
9. RETRACTED: Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer.
Yuan Z; Qu X; Wang Y; Zhang DY; Luo JC; Jia N; Zhang ZT
Colloids Surf B Biointerfaces; 2015 Apr; 128():489-497. PubMed ID: 25779606
[TBL] [Abstract][Full Text] [Related]
10. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
11. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA.
Nair K L; Jagadeeshan S; Nair SA; Kumar GS
Int J Nanomedicine; 2011; 6():1685-97. PubMed ID: 21980233
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Characterization of PLGA-PEG Thymoquinone Nanoparticles and Its Cytotoxicity Effects in Tamoxifen-Resistant Breast Cancer Cells.
Ahmad R; Kaus NHM; Hamid S
Adv Exp Med Biol; 2020; 1292():65-82. PubMed ID: 30560443
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
[TBL] [Abstract][Full Text] [Related]
14. Physical PEGylation Enhances The Cytotoxicity Of 5-Fluorouracil-Loaded PLGA And PCL Nanoparticles.
Ashour AE; Badran M; Kumar A; Hussain T; Alsarra IA; Yassin AEB
Int J Nanomedicine; 2019; 14():9259-9273. PubMed ID: 31819428
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-Fluorouracil and Chrysin.
Khaledi S; Jafari S; Hamidi S; Molavi O; Davaran S
J Biomater Sci Polym Ed; 2020 Jun; 31(9):1107-1126. PubMed ID: 32249693
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
17. Antitumor Efficacy and Toxicity of 5-Fluorouracil-Loaded Poly(Lactide Co-glycolide) Pellets.
Leelakanok N; Geary SM; Salem AK
J Pharm Sci; 2018 Feb; 107(2):690-697. PubMed ID: 29031952
[TBL] [Abstract][Full Text] [Related]
18. Influence of PEGylation on PLGA nanoparticle properties, hydrophobic drug release and interactions with human serum albumin.
Samkange T; D'Souza S; Obikeze K; Dube A
J Pharm Pharmacol; 2019 Oct; 71(10):1497-1507. PubMed ID: 31385295
[TBL] [Abstract][Full Text] [Related]
19. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer.
Handali S; Moghimipour E; Rezaei M; Ramezani Z; Dorkoosh FA
Pharm Dev Technol; 2020 Feb; 25(2):206-218. PubMed ID: 31648589
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]